Heart failure (HF) is a leading cause of morbidity and mortality worldwide. Testing for natriuretic peptide markers, such as B-type natriuretic peptide (BNP) or N-terminal proBNP (NT-proBNP), has ...

the study shows that BNP is a strong prognostic indicator in heart failure, irrespective of disease stage. Furthermore, BNP appears to be superior to established prognostic indicators, and might ...

BNP is a “stretch” hormone that indicates stretching or increased pressure that occurs with HF. Based on the stage of your heart failure, a doctor will work with you to create a treatment plan ...

An assay measuring N-terminal pro-BNP, or NT-proBNP, is more sensitive to detect heart failure and used in many institutions. The levels of BNP and NT-proBNP are essentially the same in normal ...

Chronic heart failure ... AHA heart failure staging in that NYHA allows movement from any one class to another while the ACC/AHA system only allows unidirectional progression of stages (A→B ...

The STARS-BNP trial [42] was the first large trial to demonstrate improved outcomes using a natriuretic peptide-guided approach in patients with HF. The investigators enrolled 220 participants ...